Skip to main content
Clinical Trials/NL-OMON26885
NL-OMON26885
Not Yet Recruiting
N/A

Randomized controlled trial to assess the effect of vitamin D plus K supplementation on the rate of elastin degradation in COPD

one0 sites40 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
COPD, chronic obstructive pulmonary disease.
Sponsor
one
Enrollment
40
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
one

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with COPD based on post\-bronchodilator FEV1/FVC \<0\.70 according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria.
  • Serum 25(OH)D\<50 nmol/L
  • Age \=40 and \=75 years at screening visit

Exclusion Criteria

  • Subjects using vitamin K as supplements \<3 months prior to the screening visit
  • Use of vitamin K antagonists (i.e acenocoumarol, fenprocoumon) in 12 months prior to the screening visit
  • Exacerbation \<6 weeks prior to the screening visit
  • Use of digoxin and/or thiazide diuretics
  • Hypercalcemia (i.e. corrected calcium for albumin \>2\.8 mmol/L)
  • Kidney stones in medical history
  • Severe renal failure (i.e. eGFR \< 30 ml/min/1\.73 m2\)
  • Hyperparathyroidism

Outcomes

Primary Outcomes

Not specified

Similar Trials